A mathematical model of cellular swelling in Neuromyelitis optica

A mathematical model of cellular swelling in Neuromyelitis optica

Neuromyelitis Optica (NMO) is a severe neuro-inflammatory disease of the central nervous system characterized by predominant damage to the optic nerve and of the spinal cord. The pathogenic antibody found in the majority of patients targets the AQP4 channels on astrocytic endfeet and causes the cell...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Laranjeira, S, Symmonds, M, Palace, J, Payne, S, Orlowski, P
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Elsevier 2017

Míreanna comhchosúla

The borderland of neuromyelitis optica.
de réir: Matthews, L, et al.
Foilsithe / Cruthaithe: (2009)

Use of mitoxantrone in neuromyelitis optica.
de réir: Kitley, J, et al.
Foilsithe / Cruthaithe: (2011)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
de réir: Waters, P, et al.
Foilsithe / Cruthaithe: (2015)

Magnetic resonance imaging in neuromyelitis optica.
de réir: Tackley, G, et al.
Foilsithe / Cruthaithe: (2014)

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
de réir: Elsone, L, et al.
Foilsithe / Cruthaithe: (2012)

A practical guide to the treatment of neuromyelitis optica.
de réir: Palace, J, et al.
Foilsithe / Cruthaithe: (2012)

The evolving clinical spectrum of neuromyelitis optica
de réir: Viegas, S, et al.
Foilsithe / Cruthaithe: (2008)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
de réir: Matthews, L, et al.
Foilsithe / Cruthaithe: (2014)

Neuroimmunology: towards more-accurate diagnosis in neuromyelitis optica.
de réir: Fujihara, K, et al.
Foilsithe / Cruthaithe: (2014)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
de réir: Matthews, L, et al.
Foilsithe / Cruthaithe: (2013)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
de réir: Collongues, N, et al.
Foilsithe / Cruthaithe: (2013)

Neuromyelitis Optica
de réir: Goyal V, et al.
Foilsithe / Cruthaithe: (2009-10-01)

Neuromyelitis optica
de réir: Jacob Anu, et al.
Foilsithe / Cruthaithe: (2007-01-01)

Seasonal pattern of variation in neuromyelitis optica relapses
de réir: Elsone, L, et al.
Foilsithe / Cruthaithe: (2012)

NMO-IgG in the diagnosis of neuromyelitis optica.
de réir: Jarius, S, et al.
Foilsithe / Cruthaithe: (2007)

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.
de réir: Viegas, S, et al.
Foilsithe / Cruthaithe: (2009)

Treatment of Neuromyelitis Optica: Review and Recommendations.
de réir: Kimbrough, D, et al.
Foilsithe / Cruthaithe: (2012)

Differential diagnosis of neuromyelitis optica spectrum disorders
de réir: Sung-Min Kim, et al.
Foilsithe / Cruthaithe: (2017-07-01)

Treatment of neuromyelitis optica: Review and recommendations
de réir: Kimbrough, D, et al.
Foilsithe / Cruthaithe: (2012)

NEUROMYELITIS OPTICA IN SOUTH WALES AND THE SOUTH WEST OF ENGLAND
de réir: Luppe, S, et al.
Foilsithe / Cruthaithe: (2012)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?
de réir: Downer, J, et al.
Foilsithe / Cruthaithe: (2012)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?
de réir: Downer, J, et al.
Foilsithe / Cruthaithe: (2012)

Influence of pregnancy on neuromyelitis optica spectrum disorder.
de réir: Kim, W, et al.
Foilsithe / Cruthaithe: (2012)

Pregnancy and neuromyelitis optica
de réir: Qiu-ying MA, et al.
Foilsithe / Cruthaithe: (2016-10-01)

An audit of the diagnostic usefulness of the NMO-IgG assay for neuromyelitis optica
de réir: Littleton, E, et al.
Foilsithe / Cruthaithe: (2006)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
de réir: Paul, F, et al.
Foilsithe / Cruthaithe: (2007)

Neuromyelitis optica relapses: race and rate, immunosuppression and impairment
de réir: Tackley, G, et al.
Foilsithe / Cruthaithe: (2016)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
de réir: Waters, P, et al.
Foilsithe / Cruthaithe: (2016)

Racial differences in neuromyelitis optica spectrum disorder
de réir: Kim, S, et al.
Foilsithe / Cruthaithe: (2018)

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
de réir: Kitley, J, et al.
Foilsithe / Cruthaithe: (2012)

The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
de réir: Nour, M, et al.
Foilsithe / Cruthaithe: (2014)

Paroxysmal dystonia and neuromyelitis optica
de réir: Felipe R. Schmidt, et al.
Foilsithe / Cruthaithe: (2012-04-01)

METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES
de réir: Kitley, J, et al.
Foilsithe / Cruthaithe: (2012)

Prognosis of Relapsing Neuromyelitis Optica
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (2003-03-01)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
de réir: Friedemann Paul, et al.
Foilsithe / Cruthaithe: (2007-04-01)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.
de réir: Kitley, J, et al.
Foilsithe / Cruthaithe: (2014)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials
de réir: Kitley, J, et al.
Foilsithe / Cruthaithe: (2014)

Multisystem involvement in neuromyelitis optica
de réir: Megan M Langille, et al.
Foilsithe / Cruthaithe: (2015-01-01)

Good response to Ofatumumab in a child with severe relapsing Neuromyelitis Optica
de réir: Sedani, S, et al.
Foilsithe / Cruthaithe: (2012)

NEUROMYELITIS OPTICA SPECTRUM DISORDER AND CMV RETINITIS: A CASE REPORT
de réir: George, J, et al.
Foilsithe / Cruthaithe: (2012)